Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Phone717-761-2633
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$21.64 billion
Profitability
Miscellaneous
Employees51,000
Next Earnings Date6/26/2019 (Estimated)
OptionableOptionable
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
When did Rite Aid's stock split? How did Rite Aid's stock split work?
Rite Aid shares reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) released its quarterly earnings data on Thursday, April, 11th. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.60) by $0.40. The firm had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.56 billion. Rite Aid had a negative return on equity of 1.21% and a negative net margin of 1.95%. During the same period in the previous year, the firm earned ($0.20) EPS. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid updated its FY 2020 earnings guidance on Thursday, April, 11th. The company provided earnings per share guidance of $-0.01-0.04 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.02. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $22.09 billion.
What price target have analysts set for RAD?
6 brokers have issued twelve-month price objectives for Rite Aid's shares. Their forecasts range from $20.00 to $120.00. On average, they anticipate Rite Aid's share price to reach $44.00 in the next year. This suggests a possible upside of 387.8% from the stock's current price. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 2 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.
Has Rite Aid been receiving favorable news coverage?
News coverage about RAD stock has been trending somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rite Aid earned a news impact score of -1.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the near term.
Are investors shorting Rite Aid?
Rite Aid saw a increase in short interest in the month of April. As of April 15th, there was short interest totalling 207,551,625 shares, an increase of 23.0% from the March 29th total of 168,738,575 shares. Based on an average trading volume of 27,227,426 shares, the days-to-cover ratio is presently 7.6 days. Approximately 390.9% of the company's stock are sold short. View Rite Aid's Current Options Chain.
Who are some of Rite Aid's key competitors?
What other stocks do shareholders of Rite Aid own?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, CEO & Director (Age 56)
- Mr. Kermit Ray Crawford, Pres & COO (Age 60)
- Mr. Bryan B. Everett, Chief Operating Officer (Age 46)
- Mr. Darren Wayne Karst, Exec. Officer (Age 59)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy & Retail Operations (Age 49)
Who are Rite Aid's major shareholders?
Rite Aid's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (138.27%), OppenheimerFunds Inc. (92.76%), JPMorgan Chase & Co. (46.77%), Geode Capital Management LLC (22.70%), Northern Trust Corp (22.55%) and Charles Schwab Investment Management Inc. (17.68%). View Institutional Ownership Trends for Rite Aid.
Which major investors are selling Rite Aid stock?
RAD stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, BlackRock Inc., California Public Employees Retirement System, Alpine Global Management LLC, Ladenburg Thalmann Financial Services Inc., Creative Planning, Northern Trust Corp and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Rite Aid.
Which major investors are buying Rite Aid stock?
RAD stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Jacobs Levy Equity Management Inc., Charles Schwab Investment Management Inc., Geode Capital Management LLC, Connor Clark & Lunn Investment Management Ltd., Numen Capital LLP, Dupont Capital Management Corp and BNP Paribas Arbitrage SA. View Insider Buying and Selling for Rite Aid.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $9.02.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $486.19 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe.
What is Rite Aid's official website?
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
